Currently I am a Drug Metabolism and Pharmacokinetics (DMPK) Scientist at Janssen Pharmaceutica, the Pharmaceutical Companies of Johnson & Johnson. My focus is on mechanism-based drug disposition and the use of novel micro-physiological systems (MPS) for that purpose. At Janssen and during my postdoctoral research at the VIB – Flemish Institute for Biotechnology (University of Ghent, Belgium) and Stanford University (USA) and my PhD in pharmacology at University of Halle (Germany), my research has centered around the intestine and arches from in vivo and in vitro disease modelling to the use of 2D and 3D intestinal in vitro tools for ADME (absorption, distribution, metabolism, excretion) and safety assessment of compounds.
Currently I am a Drug Metabolism and Pharmacokinetics (DMPK) Scientist at Janssen Pharmaceutica, the Pharmaceutical Companies of Johnson & Johnson. My focus is on mechanism-based drug disposition and the use of novel micro-physiological systems (MPS) for that purpose. At Janssen and during my postdoctoral research at the VIB – Flemish Institute for Biotechnology (University of Ghent, Belgium) and Stanford University (USA) and my PhD in pharmacology at University of Halle (Germany), my research has centered around the intestine and arches from in vivo and in vitro disease modelling to the use of 2D and 3D intestinal in vitro tools for ADME (absorption, distribution, metabolism, excretion) and safety assessment of compounds.